At a glance
- Originator Nippon Shinyaku
- Class Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 16 Jan 2007 Discontinued - Phase-I for Overactive bladder in Japan (unspecified route)
- 16 Jan 2007 Discontinued - Phase-II for Overactive bladder in Europe (unspecified route)
- 08 May 2006 This compound is still in active development for Overactive bladder